1-4 of 4
Friedrich Cremer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

High-Dose Therapy with Peripheral Blood Stem Cell Transplantation for Patients with Multiple Myeloma: Prognostic Impact of Chromosomal Aberrations and Correlation with the ISS-Score

Kai Neben, MD, Anna Jauch, Ph.D., Dirk Hose, MD, Friedrich Cremer, MD, Christiane Heiss, Thomas Hielscher, Uta Bertsch, MD, Ulrike Klein, MD, Jens Hillengass, MD, Anthony D. Ho, MD, Hartmut Goldschmidt, MD
Journal: Blood
Blood (2008) 112 (11): 2708.
https://doi.org/10.1182/blood.V112.11.2708.2708
Published: 2008
Journal Articles

CD56 as Prognostic Factor in Patients with Multiple Myeloma Treated by High-Dose Chemotherapy and Autologous Stem Cell Transplantation.

Michael Hundemer, MD, Ulrike Klein, MD, Dirk Hose, MD, Friedrich Cremer, MD, Marc Raab, MD, Marion Moos, PhD, Anthony D. Ho, MD, Hartmut Goldschmidt, MD
Journal: Blood
Blood (2004) 104 (11): 947.
https://doi.org/10.1182/blood.V104.11.947.947
Published: 2004
Journal Articles

The Human Plasma Cell Gene Expression Program.

John De Vos, MD, PhD, Dirk Hose, MD, PhD, Thierry Reme, MD, PhD, Hartmut Goldschmidt, MD, PhD, Jean-Francois Rossi, MD, PhD, Friedrich Cremer, MD, PhD, Bernard Klein, PhD
Journal: Blood
Blood (2004) 104 (11): 3242.
https://doi.org/10.1182/blood.V104.11.3242.3242
Published: 2004
Journal Articles

A New Method for Predictor Calculation Based on Signed-Rank Call Algorithms. Application to Microarray Gene Expression Analysis of Human Multiple Myeloma.

Thierry X. Reme, Dirk Hose, John De Vos, Hartmut Goldschmidt, Friedrich Cremer, Bernard Klein
Journal: Blood
Blood (2004) 104 (11): 4876.
https://doi.org/10.1182/blood.V104.11.4876.4876
Published: 2004